TRIB3 and Obesity: Therefore, silencing TRB3 endorses autophagy and UPS by interrupting the TRB3/p62 interaction and restoring the p62 cargo functions in cancer cells, which may provide an accessible targeted therapy approach for patients with T2D- or obesity-related cancers.